{
    "doi": "https://doi.org/10.1182/blood.V106.11.2104.2104",
    "article_title": "Telomere Length Identifies Two Distinct Populations with Different Outcome among VH-Unmutated CLL Patients. ",
    "article_date": "November 16, 2005",
    "session_type": "Poster Sessions",
    "abstract_text": "Introduction Telomere restriction fragments (TRF) length is a well-known prognostic indicator in CLL. Long telomeres have been associated with VH-mutated status, while VH-unmutated patients are regarded as having uniformly short telomeres. However, little is known on cases in which discordance exists between these two parameters. Patients and methods 138 B-CLL patients were analyzed for TRF length and VH mutational status. All samples were taken before the start of anti-CLL treatment. M/F ratio was 93/45. Median age was 60 years. According to Binet staging, 82 patients were A, 30 B and 26 C. CD38 and ZAP70 expression and FISH for Ch 11, 12, 13, 17, were available in 72% of patients. Median follow-up was 33 months (range 6\u2013290). TRF length was evaluated by Southern blot as previously described (Ladetto M et al, Blood 2004). VH mutational status was evaluated by direct sequencing according to standard methods. Results VH sequencing was successful in 127 patients: 82 were VH-mutated and 45 VH-unmutated. Median TRF length was 6097bp (1465\u201314837). As expected VH-unmutated patients had shorter telomeres (median 4000bp) compared to VH-mutated patients (median 7399bp) (p99% vs H98%). In addition they showed no difference for all the available (previously mentioned) biological and clinical parameters. However the two population had significant differences in terms of clinical outcome: 5-year PFS was 22% in concordant patients and 55% in discordant (p<0.05) (fig1b). Moreover, only 1 patient has already died among discordant patients as opposed to 9 among concordant (fig1c). Of note, the outcome of discordant patients was not significantly different from that of VH-mutated patients. The role of telomere length as survival predictor was further supported by performing univariate and multivariate analysis indicating that TRF length is the most powerful prognostic indicator among those considered (age, sex, Binet, CD38, ZAP70, FISH and mutational status). Conclusion VH-unmutated patients are highly heterogeneous and this heterogeneity can be revealed through evaluation of TRF length. View large Download slide Figure View large Download slide Figure  Close modal",
    "topics": [
        "binet staging system",
        "brachial plexus neuritis",
        "follow-up",
        "idiopathic guttate hypomelanosis",
        "immunoglobulin heavy chains",
        "southern blot assay",
        "telomere",
        "zap-70 kinase",
        "treatment outcome",
        "heterogeneity"
    ],
    "author_names": [
        "Irene Ricca, MD",
        "Alberto Rocci, MD",
        "Daniela Drandi, PhD",
        "Mara Compagno, PhD",
        "Roberto Francese, PhD",
        "Paola Omede\u0300, PhD",
        "Loredana Santo, MD",
        "Michela Rosace, PhD",
        "Federica De Marco, MD",
        "Monica Astolfi, PhD",
        "Chiara Lobetti Bodoni, MD",
        "Maria Dell\u2019Aquila, PhD",
        "Sonia Vallet, MD",
        "Luciana Bergui, MD",
        "Andrea Gallamini, MD",
        "Carlo Marinone, MD",
        "Mario Boccadoro, MD",
        "Corrado Tarella, MD",
        "Marco Ladetto, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Irene Ricca, MD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Alberto Rocci, MD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Daniela Drandi, PhD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mara Compagno, PhD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Roberto Francese, PhD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paola Omede\u0300, PhD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Loredana Santo, MD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michela Rosace, PhD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Federica De Marco, MD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Monica Astolfi, PhD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Chiara Lobetti Bodoni, MD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Dell\u2019Aquila, PhD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sonia Vallet, MD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luciana Bergui, MD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andrea Gallamini, MD",
            "author_affiliations": [
                "Divisione di Ematologia, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carlo Marinone, MD",
            "author_affiliations": [
                "Divisione Medicina Generale VII, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mario Boccadoro, MD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Corrado Tarella, MD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marco Ladetto, MD",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy"
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-04-28T09:43:25",
    "is_scraped": "1"
}